Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04276090 · ClinicalTrials.gov registry record · NA
Codman Catheter/Synchromed Pump Hepatic Artery Chemotherapy for Unresectable Colorectal Metastases/Intrahepatic Cholangiocarcinoma
A NA study, sponsored by Michael J Cavnar, MD.
- Terminated
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT04276090 is a NA study that was terminated before completion, run by Michael J Cavnar, MD. The registered enrollment target is 21 participants.
The verdict
NCT04276090, a NA study, was terminated before completion, sponsored by Michael J Cavnar, MD.
- TERMINATED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
Due to discontinuation of the Codman C3000 pump, an alternate device is necessary to continue serving patients in need of hepatic arterial infusion chemotherapy. This study aims to test the safety of hepatic artery infusion pump placement, a standard surgical procedure, and intraarterial chemotherapy initiation with the standard medication floxuridine (FUDR), using the Medtronic Synchromed II pump combined with the Codman arterial catheter in patients with unresectable (not removable by surgery) liver metastases from colorectal cancer and unresectable intrahepatic cholangiocarcinoma. This study will determine if complication and pump loss rates will be similar to previously published rates for the Codman system.
Interventions
- DEVICE Hepatic artery infusion pump placement using the Synchromed II pump and the Codman tapered arterial catheter.
- DRUG Hepatic artery infusion pump floxuridine and dexamethasone
- DRUG Systemic chemotherapy for colorectal liver metastases
- DRUG Systemic chemotherapy for intrahepatic cholangiocarcinoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2020-05-01 |
| Est. Completion | 2022-06-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04276090
The ClinicalTrials.gov registry entry for NCT04276090 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michael J Cavnar, MD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Hepatic artery infusion pump placement using the Synchromed II pump and the Codman tapered arterial catheter. is the first listed.
NCT04276090 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04276090 about?
NCT04276090 is a clinical study titled "Codman Catheter/Synchromed Pump Hepatic Artery Chemotherapy for Unresectable Colorectal Metastases/Intrahepatic Cholangiocarcinoma". Due to discontinuation of the Codman C3000 pump, an alternate device is necessary to continue serving patients in need of hepatic arterial infusion chemotherapy. This study aims to test the safety of hepatic artery infusion pump placement, a standard surgical procedure, and intraarterial chemotherap...
What is the current status of trial NCT04276090?
This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2020-05-01. Estimated completion is 2022-06-14.
What interventions are being tested in trial NCT04276090?
The interventions under investigation include: Hepatic artery infusion pump placement using the Synchromed II pump and the Codman tapered arterial catheter. (DEVICE), Hepatic artery infusion pump floxuridine and dexamethasone (DRUG), Systemic chemotherapy for colorectal liver metastases (DRUG), Systemic chemotherapy for intrahepatic cholangiocarcinoma (DRUG).
Who is sponsoring clinical trial NCT04276090?
This trial is sponsored by Michael J Cavnar, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.